Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhu, B.
Right arrow Articles by Kyprianou, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, B.
Right arrow Articles by Kyprianou, N.
[Cancer Research 66, 8640-8647, September 1, 2006]
© 2006 American Association for Cancer Research


Cell, Tumor, and Stem Cell Biology

Prohibitin and Cofilin Are Intracellular Effectors of Transforming Growth Factor ß Signaling in Human Prostate Cancer Cells

Beibei Zhu1, Kei Fukada2, Haining Zhu2 and Natasha Kyprianou1,2

1 Division of Urology and 2 Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, Kentucky

Requests for reprints: Natasha Kyprianou, Division of Urology, MS-283, University of Kentucky Medical Center, 800 Rose Street, Lexington, KY 40536-0298. Phone: 859-323-9812; Fax: 859-323-1944; E-mail: natasha{at}uky.edu.

A proteomic analysis was pursued to identify new signaling effectors of transforming growth factor ß1 (TGF-ß1) that serve as potential intracellular effectors of its apoptotic action in human prostate cancer cells. The androgen-sensitive and TGF-ß-responsive human prostate cancer cells, LNCaP TßRII, were used as in vitro model. In response to TGF-ß, significant posttranslational changes in two proteins temporally preceded apoptotic cell death. TGF-ß mediated the nuclear export of prohibitin, a protein involved in androgen-regulated prostate growth, to the cytosol in the LNCaP TßRII cells. Cofilin, a protein involved in actin depolymerization, cell motility, and apoptosis, was found to undergo mitochondrial translocation in response to TGF-ß before cytochrome c release. Loss-of-function approaches (small interfering RNA) to silence prohibitin expression revealed a modest decrease in the apoptotic response to TGF-ß and a significant suppression in TGF-ß-induced cell migration. Silencing Smad4 showed that the cellular localization changes associated with prohibitin and cofilin action in response to TGF-ß are independent of Smad4 intracellular signaling. (Cancer Res 2006; 66(17): 8640-7)




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
C. Rojas-Cartagena, P. Ortiz-Pineda, F. Ramirez-Gomez, E. C. Suarez-Castillo, V. Matos-Cruz, C. Rodriguez, H. Ortiz-Zuazaga, and J. E. Garcia-Arraras
Distinct profiles of expressed sequence tags during intestinal regeneration in the sea cucumber Holothuria glaberrima
Physiol Genomics, October 19, 2007; 31(2): 203 - 215.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.